ADZENYS XR-ODT 18.8 MG TABLET

Amphetamine
$19.3048per EA
DEA Schedule CII

Strength

18.8 mg/1

NDC

70165003030

Classification

Brand

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

AMPHETAMINE

Approval Type

New Drug (NDA)

FDA Application

NDA204326

On Market Since

2/16/2016

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-0.2%

3M

-0.1%

6M

+0.0%

1Y

+14.9%

3Y

+26.1%

5Y

+39.0%

All

+106.8%

Generic Alternatives

Save up to 15%

1 alternative • Same active ingredient